|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Skeldon SC and Larry Goldenberg S: Bladder
cancer: A portal into mens health. Urol Oncol. 33:40–44. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghafouri-Fard S, Nekoohesh L and
Motevaseli E: Bladder cancer biomarkers: Review and update. Asian
Pac J Cancer Prev. 15:2395–2403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du C, Gao Y, Xu S, Jia J, Huang Z, Fan J,
Wang X, He D and Guo P: KLF5 promotes cell migration by
up-regulating FYN in bladder cancer cells. FEBS Lett. 590:408–418.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Dai Q, Zeng F and Liu H: MALAT1
promotes the proliferation and metastasis of osteosarcoma cells by
activating the Rac1/JNK pathway via targeting MiR-509. Oncol Res.
2018.
|
|
8
|
Yang M, Zhai X, Ge T, Yang C and Lou G:
MiR-181a-5p promotes proliferation and invasion, and inhibits
apoptosis of cervical cancer cells via regulating inositol
Polyphosphate-5-Phosphatase A (INPP5A). Oncol Res. 26:703–712.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Li J, Xu C and Zhang X:
MicroRNA-139-5p inhibit cell proliferation and invasion by
targeting RHO-associated coiled-coil containing protein kinase 2 in
ovarian cancer. Oncol Res. 26:411–420. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Hui Y, Li X and Jia Q: Silencing
of lncRNA-CCDC26 restrains the growth and migration of glioma cells
in vitro and in vivo via targeting miR-203. Oncol Res.
26:1143–1154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang C, Zhou B, Liu M, Liu Y and Gao R:
miR-126-5p restoration promotes cell apoptosis in cervical cancer
by targeting Bcl2l2. Oncol Res. 25:463–470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo C and Qiu J: MiR-181a inhibits
cervical cancer development via downregulating GRP78. Oncol Res.
25:1341–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Wu Q, Xu B, Wang P, Fan W, Cai Y,
Gu X and Meng F: MiR-124 exerts tumor suppressive functions on the
cell proliferation, motility and angiogenesis of bladder cancer by
fine-tuning UHRF1. FEBS J. 282:4376–4388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Cheng Y, Li P, Tao J, Deng X,
Zhang X, Gu M, Lu Q and Yin C: A lentiviral sponge for miRNA-21
diminishes aerobic glycolysis in bladder cancer T24 cells via the
PTEN/PI3K/AKT/mTOR axis. Tumour Biol. 36:383–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Z, Zhang Y, Cao R, Li L, Zhong K,
Chen Q and Xiao J: MiR-5195-3p inhibits proliferation and invasion
of human bladder cancer cells by directly targeting oncogene KLF5.
Oncol Res. 25:1081–1087. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun DK, Wang JM, Zhang P and Wang YQ:
MicroRNA-138 regulates metastatic potential of bladder cancer
through ZEB2. Cell Physiol Biochem. 37:2366–2374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang Z, Li S, Xu X, Xu X, Wang X, Wu J,
Zhu Y, Hu Z, Lin Y, Mao Y, et al: MicroRNA-576-3p inhibits
proliferation in bladder cancer cells by targeting cyclin D1. Mol
Cells. 38:130–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Riquelme I, Tapia O, Leal P, Sandoval A,
Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM,
et al: miR-101-2, miR-125b-2 and miR-451a act as potential tumor
suppressors in gastric cancer through regulation of the
PI3K/AKT/mTOR pathway. Cell Oncol (Dordr). 39:23–33. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng F, Liao YJ, Cai MY, Liu TH, Chen SP,
Wu PH, Wu L, Bian XW, Guan XY, Zeng YX, et al: Systemic delivery of
microRNA-101 potently inhibits hepatocellular carcinoma in vivo by
repressing multiple targets. PLoS Genet. 11:e10048732015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Q, Liu T, Zhang T, Du S, Xie GX, Lin
X, Chen L and Yuan Y: MiR-101 sensitizes human nasopharyngeal
carcinoma cells to radiation by targeting stathmin 1. Mol Med Rep.
11:3330–3336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang K, Zhang Y, Ren K, Zhao G, Yan K and
Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by
downregulation of EZH2 expression. Oncol Rep. 32:2143–2149. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Li L, Guo R, Li X, Lu Y, Guan X,
Gitau SC, Wang L, Xu C, Yang B and Shan H: miR-101 promotes breast
cancer cell apoptosis by targeting Janus kinase 2. Cell Physiol
Biochem. 34:413–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lei Y, Li B, Tong S, Qi L, Hu X, Cui Y, Li
Z, He W, Zu X, Wang Z and Chen M: miR-101 suppresses vascular
endothelial growth factor C that inhibits migration and invasion
and enhances cisplatin chemosensitivity of bladder cancer cells.
PLoS One. 10:e01178092015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Qi F, Cao Y, Chen M and Zu X:
Down-regulated microRNA-101 in bladder transitional cell carcinoma
is associated with poor prognosis. Med Sci Monit. 20:812–817. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bu Q, Fang Y, Cao Y, Chen Q and Liu Y:
Enforced expression of miR-101 enhances cisplatin sensitivity in
human bladder cancer cells by modulating the cyclooxygenase-2
pathway. Mol Med Rep. 10:2203–2209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang
Y, Liu J, Liu W and Liu X: MicroRNA-101 inhibits the proliferation
and invasion of bladder cancer cells via targeting c-FOS. Mol Med
Rep. 14:2651–2656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Chang H, Rattner A and Nathans J:
Frizzled receptors in development and disease. Curr Top Dev Biol.
117:113–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ueno K, Hirata H, Majid S, Yamamura S,
Shahryari V, Tabatabai ZL, Hinoda Y and Dahiya R: Tumor suppressor
microRNA-493 decreases cell motility and migration ability in human
bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer
Ther. 11:244–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang
J, Huang A and Tang H: Downregulation of miR-101-3p by hepatitis B
virus promotes proliferation and migration of hepatocellular
carcinoma cells by targeting Rab5a. Arch Virol. 159:2397–2410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Han C, Zhu H, Song K and Wu T:
miR-101 inhibits cholangiocarcinoma angiogenesis through targeting
vascular endothelial growth factor (VEGF). Am J Pathol.
182:1629–1639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu Z, Lin Y, Chen H, Mao Y, Wu J, Zhu Y,
Xu X, Xu X, Li S, Zheng X and Xie L: MicroRNA-101 suppresses
motility of bladder cancer cells by targeting c-Met. Biochem
Biophys Res Commun. 435:82–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X,
Wang M, Huang C, Wang L, Zeng F and Jiang G: LncRNA SPRY4-IT1
sponges miR-101-3p to promote proliferation and metastasis of
bladder cancer cells through up-regulating EZH2. Cancer Lett.
388:281–291. 2017. View Article : Google Scholar : PubMed/NCBI
|
